Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib

Category Primary study
JournalTranslational Lung Cancer Research
Year 2021
This article has no abstract
Epistemonikos ID: 42bce32c3f15be5fef3470b2dbb12635b2315a3e
First added on: Feb 12, 2025